Process Development Engineer II, OT Data Management

Regeneron·
Tarrytown, New York, United States of America
2w ago
Full-timeMidResearch & Preclinical DevelopmentUnknownUnknownBachelors
$94K - $153K/yr

Description

The Data Enablement and Analytics (DEA) team drives the future of digitalization within the Product, Analytics and Process Development (PAPD) organization. By making data usable, useful, and impactful DEA accelerates process development, supporting Regeneron’s mission to use the power of science to bring new medicines to patients over and over again. In this role, you will enhance and maintain Operational Technology (OT) data systems, platforms, and tools that deliver high-quality data to lab specialists for real-time decision-making and offline analysis. You’ll implement value-focused data management solutions that increase asset value, meet immediate business needs, and build scalable data capabilities for the future.

Requirements

BS in Computer Science, Information Systems, Biomedical/Chemical/Electrical Engineering, or related field with 7-8+ years of proven experience, or MS with 3+ years. 3+ years configuring AVEVA PI Historian and Ignition SCADA systems. SQL experience in a database owner role. Demonstrated proficiency in design, deployment, and lifecycle management of OT data systems across high-availability industrial architectures. Familiarity with control systems architecture, industry standards and communication protocols (ISA-95, S88, OPC, MQTT). Working knowledge of continuous and batch manufacturing processes, associated data sources, software integration, consumption and data analytics tools. Foundational knowledge of lab-based automation software (e.g. Unicorn, Biobrain Supervise, FactoryTalk). Growing proficiency in Python scripting. Familiarity with the concepts of Industry 4.0, digitalization, and IT/OT convergence.
Regeneron

Regeneron

BIOTECHNOLOGY

Small Molecules, Biologics

LocationTARRYTOWN, NY
Employees13,000
Open Jobs457
OphthalmologyOncologyImmunologyDermatologyRare Diseases
View Company Profile

Pipeline

AfliberceptN/A
CemiplimabN/A
DupilumabN/A
Sodium-glucose cotransporter 2 inhibitorsN/A
Non-InterventionalN/A